<DOC>
	<DOCNO>NCT00487214</DOCNO>
	<brief_summary>The purpose study evaluate range target IOPs set glaucoma patient start monotherapy bimatoprost evaluate patient physician satisfaction bimatoprost `` real-world '' setting</brief_summary>
	<brief_title>Internet-based , Naturalistic Evaluation Tolerability Individual Patient Target Pressures With Bimatoprost 0.03 % Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Patients either openangle glaucoma ocular hypertension eligible need bilateral IOP reduction beyond achieve current medication , intolerant IOPlowering medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>